Astrocyte calcium signaling transforms cholinergic modulation to cortical plasticity in vivo

J Neurosci. 2011 Dec 7;31(49):18155-65. doi: 10.1523/JNEUROSCI.5289-11.2011.

Abstract

Global brain state dynamics regulate plasticity in local cortical circuits, but the underlying cellular and molecular mechanisms are unclear. Here, we demonstrate that astrocyte Ca(2+) signaling provides a critical bridge between cholinergic activation, associated with attention and vigilance states, and somatosensory plasticity in mouse barrel cortex in vivo. We investigated first whether a combined stimulation of mouse whiskers and the nucleus basalis of Meynert (NBM), the principal source of cholinergic innervation to the cortex, leads to enhanced whisker-evoked local field potential. This plasticity is dependent on muscarinic acetylcholine receptors (mAChR) and N-methyl-d-aspartic acid receptors (NMDARs). During the induction of this synaptic plasticity, we find that astrocytic [Ca(2+)](i) is pronouncedly elevated, which is blocked by mAChR antagonists. The elevation of astrocytic [Ca(2+)](i) is crucial in this type of synaptic plasticity, as the plasticity could not be induced in inositol-1,4,5-trisphosphate receptor type 2 knock-out (IP(3)R2-KO) mice, in which astrocytic [Ca(2+)](i) surges are diminished. Moreover, NBM stimulation led to a significant increase in the extracellular concentration of the NMDAR coagonist d-serine in wild-type mice when compared to IP(3)R2-KO mice. Finally, plasticity in IP(3)R2-KO mice could be rescued by externally supplying d-serine. Our data present coherent lines of in vivo evidence for astrocytic involvement in cortical plasticity. These findings suggest an unexpected role of astrocytes as a gate for cholinergic plasticity in the cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Action Potentials / drug effects
  • Action Potentials / genetics
  • Afferent Pathways / physiology
  • Aniline Compounds / metabolism
  • Animals
  • Astrocytes / drug effects
  • Astrocytes / physiology*
  • Atropine / pharmacology
  • Basal Nucleus of Meynert / physiology*
  • Calcium Signaling / drug effects
  • Calcium Signaling / genetics
  • Calcium Signaling / physiology*
  • Cholinergic Agents / metabolism*
  • Chromatography, High Pressure Liquid
  • Evoked Potentials, Somatosensory / drug effects
  • Evoked Potentials, Somatosensory / genetics
  • Excitatory Amino Acid Antagonists / pharmacology
  • Fluoresceins / metabolism
  • Inositol 1,4,5-Trisphosphate Receptors / deficiency
  • Male
  • Mice
  • Mice, Knockout
  • Microdialysis / methods
  • Muscarinic Antagonists / pharmacology
  • Nerve Growth Factors / metabolism
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / genetics
  • Neuronal Plasticity / physiology*
  • Neurons / drug effects
  • Neurons / metabolism
  • Physical Stimulation
  • Piperazines / pharmacology
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins / metabolism
  • Serine / pharmacology
  • Somatosensory Cortex / drug effects
  • Somatosensory Cortex / physiology*
  • Sulfonamides / metabolism
  • Thiazoles / metabolism
  • Vibrissae / innervation

Substances

  • Aniline Compounds
  • Cholinergic Agents
  • Excitatory Amino Acid Antagonists
  • Fluoresceins
  • Inositol 1,4,5-Trisphosphate Receptors
  • Muscarinic Antagonists
  • Nerve Growth Factors
  • Oregon green 488 BAPTA-1
  • Piperazines
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins
  • SR1001
  • Sulfonamides
  • Thiazoles
  • Serine
  • Atropine
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
  • Acetylcholine